62813-02-9 Usage
Uses
Used in Pharmaceutical Development:
4-Amino-1-cyclopropylpiperidine is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and biological activity make it a valuable building block for the development of new drugs, particularly those targeting neurological disorders, pain management, and other therapeutic areas where piperidine derivatives have shown efficacy.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-Amino-1-cyclopropylpiperidine serves as a starting point for the design and synthesis of novel compounds with potential therapeutic applications. Researchers leverage its chemical properties to explore new chemical entities that can modulate biological targets, leading to the discovery of innovative treatments for various diseases and conditions.
Used in Drug Discovery:
4-Amino-1-cyclopropylpiperidine is employed as a scaffold in drug discovery efforts, where its cyclopropyl ring and amino group can be modified to generate a diverse array of analogs with different biological activities. 4-Amino-1-cyclopropylpiperidine's versatility allows for the optimization of drug candidates, enhancing their potency, selectivity, and pharmacokinetic properties to improve their therapeutic potential.
Used in Chemical Synthesis:
Beyond its direct applications in drug development, 4-Amino-1-cyclopropylpiperidine also serves as a versatile intermediate in the synthesis of other organic compounds. Its reactivity and functional groups enable the formation of a wide range of chemical products, contributing to the advancement of organic chemistry and the creation of new materials and reagents for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 62813-02-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,8,1 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 62813-02:
(7*6)+(6*2)+(5*8)+(4*1)+(3*3)+(2*0)+(1*2)=109
109 % 10 = 9
So 62813-02-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H16N2/c9-7-3-5-10(6-4-7)8-1-2-8/h7-8H,1-6,9H2
62813-02-9Relevant academic research and scientific papers
KRAS G12C INHIBITORS
-
Paragraph 0337, (2020/07/25)
The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
NAPHTHALENYLOXYPROPENYL DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
-
Page/Page column 80; 166-167, (2008/12/05)
The present invention discloses novel naphthalenyloxypropenyl derivatives useful for inhibiting the enzyme activity of histone deacetylase, leading effective suppression of cancer cell proliferation
NOVEL COMPOUNDS
-
Page/Page column 107, (2008/06/13)
There is provided a compound of formula (I): processes for the manufacture thereof, pharmaceutical compositions thereof and uses in therapy.
ALKYLCARBAMOYL NAPHTHALENYLOXY- OCTENOYLHYDROXYAMIDE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PREPARATION THEREOF
-
Page/Page column 21, (2010/11/27)
This invention discloses a novel alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide derivative of formula (1) useful for inhibiting the enzyme activity of histone deacetylase, which leads to effective suppression of the cancer cell proliferation, a method for preparing same and a pharmaceutical composition comprising same.
N-Heterocyclic-9-xanthenylamines
-
, (2008/06/13)
The compounds are N-piperidinyl and pyrrolidinyl-9-xanthenylamines which are inhibitors of gastric acid secretion.
